Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview-Reference-Cited by-同舟云学术

Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview

Published:2019-07-30 Issue:10 Volume:27 Page:3729-3737
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Chan Alexandre,Hertz Daniel L.,Morales Manuel,Adams Elizabeth J.,Gordon Sharon,Tan Chia Jie,Staff Nathan P.,Kamath Jayesh,Oh Jeong,Shinde Shivani,Pon Doreen,Dixit Niharkia,D’Olimpio James,Dumitrescu Cristina,Gobbo Margherita,Kober Kord,Mayo Samantha,Pang Linda,Subbiah Ishwaria,Beutler Andreas S.,Peters Katherine B.,Loprinzi Charles,Lustberg Maryam B.^ORCID

Funder

National Institute of Health / National Cancer Institute

National Institutes of Health / National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-019-04987-8.pdf

Reference79 articles.

1. Gewandter JS, Fan L, Magnuson A et al (2013) Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer 21(7):2059–2066

2. Miaskowski C, Mastick J, Paul SM et al (2018) Impact of chemotherapy-induced neurotoxicities on adult cancer survivors’ symptom burden and quality of life. J Cancer Surviv 12(2):234–245